-
Australia hit by its eighth wave of COVID-19
According to multiple media reports, the number of COVID-19 cases in Australia has surged recently, and is experiencing the eighth wave of COVID-19, which is feared to reach "a peak for the third consecutive year" by Christmas.
18-12-2023 -
Difference between Mycoplasma Pneumoniae and COVID-19
Mycoplasma pneumoniae is an atypical pathogen. It is neither a virus nor a bacterium, but a microorganism intermediate in size between a bacterium and a virus.
06-12-2023 -
World Stroke Day: Focus on prevention
Stroke, also known as cerebrovascular disease, is a sudden occurrence of cerebrovascular circulation disorders, mainly including ischemic stroke and hemorrhagic stroke.
27-10-2023 -
Wizbiotech signed cooperation with China Agricultural University on the transformation of major scientific and technological achievements
On October 15, 2023, on the occasion of the 118th anniversary of China Agricultural University, the signing ceremony for the transformation of major scientific and technological achievements of China Agricultural University kicked off.
18-10-2023 -
These days, two reagents of WIZ been approved!
WIZ's two reagents, HBA1C assay kits (fluorescent immunochromatography) and the SARS-CoV-2 Antigen Rapid Test (Colloidal gold) (Anterior nasal) have been approved by the Medical Device Authority (MDA) of Malaysia and began market access.
06-07-2023 -
The peak of the second wave of the epidemic is imminent, how to prevent and control the SARS-CoV-2?
Academician Zhong Nanshan said at the Biomedicine and Health sub-forum of the 2023 Greater Bay Area Science Forum that the forecast based on the seirs model shows that the peak of the second wave of the SARS-CoV-2 epidemic in 2023 will occur at the end of June, about 65 million per week.
14-06-2023 -
Wiz Biotech signed a strategic cooperation agreement with Zhuqiang Large Pharmacy on COVID-19 antigen reagents
On the afternoon of December 21, Xiamen Wiz Biotech Co., Ltd. and Xiamen Zhuqiang Large Pharmacy Co., Ltd. had an in-depth discussion on how to meet citizens' demand for novel coronavirus antigen test kits, reached and established a strategic partnership, to assist Xiamen in epidemic prevention and control.
22-12-2022 -
Wiz Biotech has entered into a strategic cooperation with Xiamen Luyan Pharmacy on COVID-19 antigen reagents
On December 21, Xiamen Wiz Biotech Co., Ltd and Xiamen Luyan Pharmacy Co., Ltd signed a strategic cooperation on COVID-19 antigen test kit. Su Jinkun (Mr.), General manager of Xiamen Luyan Pharmacy, Lin Lin (Ms.), Deputy general manager of Retail Division of Luyan Group, and Wang Xiaozhen (Ms.), general manager of Wiz Biotech, Sales Director Peng Que'en (Mr.) attended the ceremony.
21-12-2022 -
2019-nCoV Antigen Test was approved by CFDA
Recently, the new coronavirus (2019-nCoV) antigen detection kit (Colloidal gold method) developed by Xiamen Wiz Biotech Co., Ltd. has been approved by the National Medical Products Administration.
12-12-2022